SATB2 may be a driving force for developing cancer stem‐like phenotypes in damaged hepatocytes where induction of stem cell markers (CD44, CD90, EpCAM, AFP and LGR5) and pluripotency maintaining factors (POU5F1/Oct4, Sox‐2, Nanog and KLF4) was prominent. The gene discussed is SATB2; the disease is cancer.